Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EONS 8 /
Cervical cancer prevention through screening and vaccination

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.05.12
Views: 5317

Silvia de Sanjose – Institut Catala d’Oncologia, Barcelona, Spain

At the European Oncology Nursing Society annual meeting in Geneva, April 2012, Silvia de Sanjose talks about results from a world-wide study on HPV and cervical cancer prevention.


HPV 16 and 18 account for 70% percent of all cervical cancer cases in the world. Currently, there are vaccines ready for these two strains; however, reaching people to vaccinate and informing them about the vaccines is a major issue.


In addition to vaccination, the development of stronger screening methods is important as cervical cancer has a longer latency period than most other cancers. A goal in improving tools for screening would be to utilise DNA analysis to allow for screening every five years instead of every year.  


Filming Supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation